These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39228048)

  • 1. Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation.
    Suwantarat N; Iamsirirak P; Chanapai J; Pakakasama S; Andersson BS; Boelens JJ; Anurathapan U; Hongeng S
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31311. PubMed ID: 39228048
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant.
    Chan WYK; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
    Pediatr Transplant; 2021 Aug; 25(5):e13945. PubMed ID: 33314508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
    Vellaichamy Swaminathan V; Ravichandran N; Ramanan KM; Meena SK; Varla H; Ramakrishnan B; Jayakumar I; Uppuluri R; Raj R
    Pediatr Transplant; 2021 Mar; 25(2):e13893. PubMed ID: 33111490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
    Anurathapan U; Hongeng S; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Charoenkwan P; Jetsrisuparb A; Sanpakit K; Rujkijyanont P; Meekaewkunchorn A; Lektrakul Y; Iamsirirak P; Surapolchai P; Satayasai W; Sirireung S; Sruamsiri R; Wahidiyat PA; Ungkanont A; Issaragrisil S; Andersson BS
    Bone Marrow Transplant; 2016 Jun; 51(6):813-8. PubMed ID: 26878659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies.
    Katsuki K; Tachibana T; Izumi A; Kim K; Suzuki T; Tanaka M; Nakajima H
    Int J Hematol; 2024 Aug; 120(2):256-261. PubMed ID: 38676859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
    Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Transplantation of Haploidentical Stem Cells and a Dose of Unrelated Cord Blood in Pediatric Patients with Thalassemia Major.
    Wang X; Zhang X; Yu U; Wang C; Yang C; Li Y; Li C; Wen F; Li C; Liu S
    Cell Transplant; 2021; 30():963689721994808. PubMed ID: 33593080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
    Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
    J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple predictor for donor-specific anti-HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation.
    Li JM; Zhang ZL; Zhao JL; Wang YQ; Gong SS; Lei H; Wang XF; Hu XX; Cai XH
    HLA; 2024 Aug; 104(2):e15625. PubMed ID: 39091273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who is the best donor for haploidentical stem cell transplantation?
    Kongtim P; Ciurea SO
    Semin Hematol; 2019 Jul; 56(3):194-200. PubMed ID: 31202430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
    Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Front Immunol; 2021; 12():674658. PubMed ID: 34093576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.
    Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J
    Ann Hematol; 2017 Apr; 96(4):703-705. PubMed ID: 28160086
    [No Abstract]   [Full Text] [Related]  

  • 13. Considerations for haploidentical versus unrelated donor transplants.
    Ciurea SO
    Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):738-742. PubMed ID: 31431699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
    Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is human leukocyte antigen-matched sibling donor transplant always better than haploidentical allograft?
    Chang YJ; Huang XJ
    Semin Hematol; 2019 Jul; 56(3):201-208. PubMed ID: 31202431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation for thalassemia major: alternative donors.
    Locatelli F; Merli P; Strocchio L
    Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in haploidentical hematopoietic stem cell transplantation.
    Vittayawacharin P; Kongtim P; Ciurea SO
    Hematology; 2024 Dec; 29(1):2366718. PubMed ID: 38889342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
    Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.